ICD-10 Code D81.0: Severe combined immunodeficiency (SCID)

Key Takeaways

ICD-10 Code D81.0 identifies severe combined immunodeficiency (SCID) with reticular dysgenesis, the rarest and most severe SCID subtype, marked by absence of both lymphocytes and myeloid cells.

D81.0 is a billable ICD-10-CM code, valid for HIPAA-covered transaction submission, and current under the FY2026 edition effective October 1, 2025.

Documentation must include immunophenotyping results, genetic or laboratory confirmation of myeloid cell absence, and the treating clinician’s clinical findings to support this specific code over sibling codes D81.1 or D81.9.

Practice management software like Pabau gives immunology and specialist practices the claims management and client record tools to support the structured documentation this code requires and reduce denial risk.

ICD-10 Code D81.0 is a billable, specific code for severe combined immunodeficiency (SCID) with reticular dysgenesis, the rarest and most severe SCID subtype, marked by absence of both lymphocytes and myeloid cells. This guide covers billable status and FY2026 validity, documentation requirements, sibling code comparisons, and the ICD-9-CM crosswalk coders and immunology clinicians need to assign the code accurately.

Other combined immunodeficiency subtypes affect T-cells and B-cells alone. Reticular dysgenesis eliminates both lymphoid and myeloid lineages, leaving patients with virtually no functional immune system from birth. Getting the code right affects reimbursement as well as the clinical record, and practices relying on structured claims management workflows reduce the missing documentation that leads to downcoding.

ICD-10 Code D81.0: Billable status and FY2026 validity

D81.0 is a billable, specific ICD-10-CM diagnosis code. It is valid for submission on HIPAA-covered transactions and has been so since October 1, 2015. The FY2026 edition, effective October 1, 2025, carries no descriptor changes or exclusion revisions. Coders can submit this code on insurance claims, Medicare, and Medicaid transactions without additional specificity qualifiers.

According to the CMS ICD-10 codes page, FY2026 update files confirm D81.0 carries no revisions from FY2025. Coders using the CDC/NCHS ICD-10-CM web tool can verify current code validity and tabular notes directly against the official release. Pabau’s diagnostic-codes library covers other conditions coders look up alongside SCID, including ICD-10 Code Z51.6.

Clinical description: What is SCID with reticular dysgenesis?

Severe combined immunodeficiency (SCID) is a group of rare, inherited primary immunodeficiency disorders in which both T-cell and B-cell immunity are profoundly impaired. D81.0 represents the most severe subtype: reticular dysgenesis.

Where other SCID variants affect lymphoid cells selectively, reticular dysgenesis eliminates both lymphocytes (T-cells and B-cells) and myeloid cells, including neutrophils. The result is a near-complete collapse of both adaptive and innate immunity from birth.

Affected infants present within weeks of life with recurrent, severe infections from bacteria, viruses, and fungi that a functional immune system would routinely neutralize.

Reticular dysgenesis is inherited as an autosomal recessive condition. Clinical literature links the condition to mutations in the AK2 gene, which encodes adenylate kinase 2, an enzyme critical to mitochondrial function in hematopoietic progenitor cells.

Molecular confirmation of the genetic basis is not always available at the time of initial coding. Documentation of the clinical phenotype, meaning absent myeloid and lymphoid populations on immunophenotyping, is sufficient to support D81.0 assignment.

Clinically, reticular dysgenesis resembles other forms of SCID but is distinguished by the additional absence of granulocytes. Bone marrow examination typically shows a block at the earliest stages of hematopoiesis. Hematopoietic stem cell transplantation (HSCT) is the standard treatment, and outcomes depend heavily on early diagnosis and transplant timing.

D81 combined immunodeficiency ICD-10 code group overview

D81 is the parent category for combined immunodeficiencies in ICD-10-CM. Its subdivisions add up to 17 billable codes, alongside four non-billable parent codes, including D81 itself, that require a more specific fifth- or sixth-character code before submission.

Coders should select the most specific subcode supported by clinical documentation rather than defaulting to D81.9 (unspecified). The table below shows the billable D81.x codes.

D81.81’s biotin-dependent carboxylase deficiencies are metabolic disorders rather than primary immune defects. They’re coded within the immunodeficiency chapter because untreated biotinidase deficiency also causes secondary immune dysfunction. Practices managing overlapping metabolic and immune presentations, including those using metabolic health EMR systems, need documentation that captures both the metabolic workup and the immune findings supporting D81.0 or its sibling codes.

Practices coding immunodeficiency disorders benefit from a clinical records system that flags incomplete workup data before a claim is submitted. Pabau’s client record tools give specialist practices structured templates to capture the immunophenotyping results and laboratory values that distinguish D81.0 from other D81.x codes.

Pabau’s diagnostic-codes hub also covers related conditions coders reference alongside immunodeficiency, including ICD-10 Code M18.0.

D81.0 coding notes: Applicable-to, excludes, and hierarchy

The ICD-10-CM tabular list includes several hierarchy and notation rules for D81.0. Coders must apply these before finalizing a claim submission.

Parent hierarchy

D81.0 sits within the following hierarchical path:

• D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
• D80-D89: Certain disorders involving the immune mechanism
• D81: Combined immunodeficiencies (parent, non-billable)
• D81.0: SCID with reticular dysgenesis (billable/specific)

Excludes notes for D81

The D81 parent category carries an Excludes 1 note. Excludes 1 means the excluded conditions cannot be coded at the same encounter as D81.0 because they are mutually exclusive diagnoses.

• Excludes 1: Autosomal recessive agammaglobulinemia (Swiss type) (D80.0)

There are no Excludes 2 notes specific to D81.0. Other primary immunodeficiency codes in the D80 and D83 ranges should not be assigned alongside D81.0 when a single, specific combined immunodeficiency diagnosis is supported by the clinical evidence.

Applicable-to notes

The ICD-10-CM tabular does not include a specific Applicable To note at the D81.0 level. The Applicable To notation appears at the D81 parent level and confirms the code block covers combined immunodeficiencies as a whole. Reticular dysgenesis is specifically named in the D81.0 descriptor and does not require an additional Applicable To qualifier.

Diagnostic criteria and documentation for reticular dysgenesis ICD-10 coding

Selecting ICD-10 Code D81.0 requires specific clinical evidence in the medical record. Immunologists and pediatricians managing SCID patients need documentation that supports the reticular dysgenesis subtype specifically, not just SCID in general.

The same documentation discipline applies across other specialties working up rare, multi-system presentations, including functional medicine practices diagnosing atypical patients. Missing documentation is the main reason claims for rare immunodeficiency codes face additional review.

The following elements should appear in the medical record before D81.0 is assigned:

• Immunophenotyping results: Lab report showing absent or severely reduced T-lymphocytes, B-lymphocytes, and natural killer (NK) cells
• Myeloid cell assessment: CBC with differential or bone marrow biopsy showing absence of neutrophils and other myeloid lineage cells
• Clinical presentation: Documentation of recurrent severe infections presenting within weeks to months of birth
• Genetic or molecular testing (if available): AK2 gene mutation confirmation strengthens specificity, though it is not required to assign D81.0 when the clinical and laboratory phenotype supports reticular dysgenesis
• Attending clinician’s narrative: The treating physician must explicitly document the diagnosis of SCID with reticular dysgenesis, not merely “combined immunodeficiency”

Practices that maintain structured electronic health records reduce the time spent locating these elements at audit. Pabau’s digital intake tools allow immunology practices to build condition-specific documentation workflows that capture immunophenotyping results, laboratory values, and clinical narrative in one place.

For broader guidance on HIPAA-compliant documentation practices, Pabau’s HIPAA documentation guide outlines the record-keeping obligations that apply to specialty practices.

Clinical documentation that holds up at audit

Pabau gives specialty practices structured digital forms, comprehensive client records, and automated workflows so the clinical evidence supporting ICD-10 Code D81.0 and other rare diagnosis codes is captured at the point of care, not chased after submission.

Book a demo

D81.0 vs. related immunodeficiency codes

Other ICD-10-CM categories besides D81 also cover immunodeficiency. Coders working with patients who present broad immunodeficiency symptoms need to distinguish D81.0 from similar codes in adjacent categories.

Selecting the wrong code misrepresents the patient’s condition, and in audits, can flag a pattern of non-specific coding. The AAPC ICD-10-CM code lookup and the WHO ICD-10 browser both provide navigable hierarchies for cross-checking code selection.

The clearest differentiator for D81.0 is myeloid cell absence. No other D81 subcode requires documented absence of granulocytes. If the patient’s CBC shows normal neutrophil counts, D81.0 is not supportable regardless of the severity of lymphopenia.

Coders working with pediatric immunology records should also confirm whether the ordering clinician distinguished between SCID and combined immunodeficiency secondary to an acquired condition, such as HIV, which falls under a different ICD-10-CM chapter entirely.

Pabau’s diagnostic-codes library also covers pediatric-adjacent conditions coders reference alongside SCID, including ICD-10 Code P51.9.

Code history and annual updates for D81.0

D81.0 has been active since the initial ICD-10-CM implementation in the United States. The code has remained stable across all fiscal year editions without descriptor revisions, billable status changes, or hierarchical restructuring.

According to ResDAC ICD code guidance, practices should verify code validity annually against the CMS update release, typically published in the summer preceding the October 1 effective date.

Coders at practices that submit claims for SCID diagnoses should confirm each fiscal year’s validity table before the annual October 1 transition. Specialty practices using EHR systems should also review how their documentation workflow handles annual code set updates.

Pabau’s direct primary care EHR guide covers how practice management platforms manage code set transitions and annual update rollouts.

ICD-9-CM crosswalk for D81.0

Practices managing legacy claims or reviewing historical records may need the ICD-9-CM equivalent for SCID with reticular dysgenesis. The General Equivalence Mapping (GEM) files published by CMS and NCHS provide the official crosswalk between ICD-9-CM and ICD-10-CM. Practices handling historical billing records should verify crosswalk accuracy through the official CMS GEM files rather than relying on commercial tools alone.

The ICD-9-CM system did not have a code specific to reticular dysgenesis. Code 279.2 (combined immunity deficiency) served as the closest equivalent, but it covered the entire combined immunodeficiency spectrum without subtype differentiation.

The transition to ICD-10-CM in October 2015 introduced the granular D81.x coding structure that lets reticular dysgenesis be distinguished from other combined immunodeficiency subtypes. Practices reviewing historical crosswalk data can refer to Pabau’s HIPAA compliance guide for how EHR systems handle legacy claim records.

Conclusion

SCID with reticular dysgenesis is the rarest, most severe form of combined immunodeficiency in the ICD-10-CM classification. Assigning D81.0 correctly requires documented myeloid cell absence alongside the standard lymphopenia criteria, a distinction that separates this code from every other sibling in the D81 group. The code is billable, HIPAA-valid, and unchanged for FY2026.

Immunology and pediatric specialty practices that capture structured laboratory and clinical narrative data at the point of care run into far fewer documentation shortfalls at claim submission. Pabau’s clinical EMR tools are built for practices where diagnostic specificity directly determines reimbursement outcomes.

To see how Pabau supports specialty documentation workflows, book a demo with the team.

Continue your research

Coding acute infections in immunocompromised patients? ICD-10 Code J22 covers documentation and billing for unspecified acute lower respiratory infection.

Need a reference for another rare, congenital diagnosis? ICD-10 Code Q20.0 covers billable status and documentation for common truncus.

Billing for point-of-care lab testing during a workup? HCPCS Code A4252 covers reagent strip billing rules for blood ketone testing.

Frequently Asked Questions